All lobbying filings

THE KPM GROUP DC LLC

Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 17, 2025

Official filing document

Bills named in this filing 8

HR 946
ORPHAN Cures Act
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025
HR 1414
Cameron’s Law
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S 832
EPIC Act of 2025

Lobbying activity 1

Health Issues

H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.